Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brachytherapy

Showing results (11-20 of 2,190) with videos related to

Pageof 219
Sort By:
Brachytherapy|June 24, 2010
The dosimetric quality of brachytherapy implants in patients with small prostate volume depends on the experience of the brachytherapy teamHong-Wei Liu, Kyle Malkoske, David Sasaki, et al.
Brachytherapy|August 7, 2010
Definitive 125I prostate brachytherapy implant for low-risk prostate cancer in a patient with an ileal pouch-anal anastomosis: a case reportEdward F Miles, John W Nelson
Brachytherapy|July 3, 2010
Point: Prostate carcinoma treatment for the young patient--the case for brachytherapyKent E Wallner
Brachytherapy|August 24, 2010
Robotic needle guide for prostate brachytherapy: clinical testing of feasibility and performanceDanny Y Song, Everette C Burdette, Jonathan Fiene, et al.
Brachytherapy|August 24, 2010
Precedence for prostate brachytherapyJesse N Aronowitz, Laval Grimard, Roger Robison
Brachytherapy|September 7, 2010
Dosimetric performance of Strut-Adjusted Volume Implant: a new single-entry multicatheter breast brachytherapy applicatorSalih Gurdalli, Robert R Kuske, Coral A Quiet, et al.
Brachytherapy|September 7, 2010
A dosimetric comparison of the Contura multilumen balloon breast brachytherapy catheter vs. the single-lumen MammoSite balloon device in patients treated with accelerated partial breast irradiation at a single institutionSheree Brown, Mark McLaughlin, Doyle Keith Pope, et al.
Brachytherapy|November 29, 2008
Toxicity and early treatment outcomes in low- and intermediate-risk prostate cancer managed by high-dose-rate brachytherapy as a monotherapyPirus Ghadjar, Tamara Keller, Cyrill A Rentsch, et al.
Brachytherapy|February 14, 2009
Favorable toxicity and biochemical control using real-time inverse optimization technique for prostate brachytherapyAdam Raben, Kyle E Rusthoven, Abrihup Sarkar, et al.
Brachytherapy|March 12, 2011
Palladium-103 eye plaque brachytherapy for primary adenocarcinoma of the ciliary body epitheliumPaul T Finger, Julia E Reid, Codrin E Iacob
Pageof 219

Showing results (11-20 of 2,190) with videos related to

Sort By:
Pageof 219
Brachytherapy|June 24, 2010
The dosimetric quality of brachytherapy implants in patients with small prostate volume depends on the experience of the brachytherapy teamHong-Wei Liu, Kyle Malkoske, David Sasaki, et al.
Brachytherapy|August 7, 2010
Definitive 125I prostate brachytherapy implant for low-risk prostate cancer in a patient with an ileal pouch-anal anastomosis: a case reportEdward F Miles, John W Nelson
Brachytherapy|July 3, 2010
Point: Prostate carcinoma treatment for the young patient--the case for brachytherapyKent E Wallner
Brachytherapy|August 24, 2010
Robotic needle guide for prostate brachytherapy: clinical testing of feasibility and performanceDanny Y Song, Everette C Burdette, Jonathan Fiene, et al.
Brachytherapy|August 24, 2010
Precedence for prostate brachytherapyJesse N Aronowitz, Laval Grimard, Roger Robison
Brachytherapy|September 7, 2010
Dosimetric performance of Strut-Adjusted Volume Implant: a new single-entry multicatheter breast brachytherapy applicatorSalih Gurdalli, Robert R Kuske, Coral A Quiet, et al.
Brachytherapy|September 7, 2010
A dosimetric comparison of the Contura multilumen balloon breast brachytherapy catheter vs. the single-lumen MammoSite balloon device in patients treated with accelerated partial breast irradiation at a single institutionSheree Brown, Mark McLaughlin, Doyle Keith Pope, et al.
Brachytherapy|November 29, 2008
Toxicity and early treatment outcomes in low- and intermediate-risk prostate cancer managed by high-dose-rate brachytherapy as a monotherapyPirus Ghadjar, Tamara Keller, Cyrill A Rentsch, et al.
Brachytherapy|February 14, 2009
Favorable toxicity and biochemical control using real-time inverse optimization technique for prostate brachytherapyAdam Raben, Kyle E Rusthoven, Abrihup Sarkar, et al.
Brachytherapy|March 12, 2011
Palladium-103 eye plaque brachytherapy for primary adenocarcinoma of the ciliary body epitheliumPaul T Finger, Julia E Reid, Codrin E Iacob
Pageof 219